Potential usefulness of siRNAs for gene therapy ofsepsis-induced multiple organ failure

siRNA 在脓毒症引起的多器官衰竭基因治疗中的潜在用途

基本信息

  • 批准号:
    18590233
  • 负责人:
  • 金额:
    $ 2.46万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Rationale: Not only better understanding of the molecular mechanisms involved in the pathogenesis of sepsis and its resultant organ failure, but also new therapeutic approaches and targets are urgently needed. Accumulating evidence suggests that apoptosis plays an important role in the pathophysiology of sepsis, and apoptosis may be potentially detrimental in septic acute lung injury (ALI). Also, vascular endothelial cell apoptosis may play a role in the pathogenesis of the septic syndrome.Objectives: We tested the hypothesis that systemic administration of small interfering RNA (siRNA) targeting Fas-associated death domain (FADD), which recruits procaspase-8 into the death-inducing signaling complex, may be protective in septic ALI and mortality We also evaluated the therapeutic efficacy of caspase-8/caspase-3 siRNAs in a murine model of polymicrobial endotoxic shock.Methods: Polymicrobial sepsis was induced by cecal ligation and puncture (CLP) in BALB/c mice. In vivo delivery of siRN … More As was performed by using a transfection reagent (Lipofectamine^(TM) RNAiMAX) at 10 hours after CLP. As a negative control, animals received non-sense (scrambled) siRNA.Measurements and Main Results: In CLP-induced septic mice, surface expression of death receptors were up-regulated and FADD was highly expressed and activated. DNA fragmentation ladder and TUNEL (transferase-mediated dUTP nick end labeling) assays showed that treatment with siRNAs suppressed apoptosis induction in lungs and vascular tissues following sepsis. Moreover, these siRNA treatments prevented the development of ALI in CLP mice, as indicated by great improvements of blood-gas derangements, histologic lung damage, and increased pulmonary inflammatory cells. Furthermore, hematoxylin/eosin-stained sections of septic aorta displayed partial detachment of endothelial cells from the basal membrane. These histopathologic changes in endothelial cells were drastically prevented by systemic treatment with FADD siRNA or caspase-8/-3 siRNAs. Finally, administration of FADD siRNA or caspase-8/-3 dramatically improved the survival of CLP mice.Conclusions: These results indicate the pathophysiological significance of the death receptor apoptotic pathway, including FADD, in septic ALI and the potential usefulness of FADD siRNA for gene therapy of the septic syndrome. In addition, gene silencing of caspase-8 and caspase-3 with siRNAs provided profound protection against polymicrobial endotoxic shock. The prevention of vascular endothelial cell apoptosis appears to be, at least in part, responsible for their beneficial effects in endotoxic shock. Less
理论基础:不仅需要更好地了解脓毒症及其导致的器官衰竭的发病机制,而且迫切需要新的治疗方法和靶点。越来越多的证据表明细胞凋亡在脓毒症的病理生理过程中起着重要作用,细胞凋亡在脓毒症急性肺损伤(ALI)中可能具有潜在的危害作用。此外,血管内皮细胞的凋亡可能在脓毒症综合征的发病机制中起作用。目的:我们验证了全身应用针对Fas相关死亡结构域(FADD)的小干扰RNA(SiRNA)可能对感染性ALI和死亡率具有保护作用的假说。我们还评价了caspase-8/caspase-3 siRNA在多菌性内毒素休克小鼠模型中的治疗效果。SiRN…的体内递送在CLP后10h使用转染剂(Lipofetamine^(TM)RNAiMAX)进行更多的检查。实验方法和主要结果:在CLP诱导的脓毒症小鼠中,死亡受体的表面表达上调,FADD高表达和激活。DNA梯状条带和TUNEL(转移酶介导的dUTP缺口末端标记)分析表明,siRNAs治疗可抑制脓毒症后肺和血管组织的细胞凋亡诱导。此外,这些siRNA治疗阻止了CLP小鼠ALI的发展,表现为血气紊乱、组织学肺损伤和肺炎性细胞增加的显著改善。此外,败血症大动脉苏木精/伊红染色切片显示内皮细胞部分脱离基底膜。用FADD siRNA或caspase-8/-3 siRNA系统治疗后,内皮细胞的这些组织病理学改变被显著地预防。结论:包括FADD在内的死亡受体凋亡通路在脓毒症ALI中具有重要的病理生理学意义,FADD siRNA在败血症综合征的基因治疗中具有潜在的应用价值。此外,通过siRNAs沉默caspase-8和caspase-3的基因,可以有效地对抗多菌素性内毒素休克。防止血管内皮细胞凋亡似乎至少在一定程度上是它们对内毒素休克的有益作用的原因。较少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pro-apoptotic gene silencing in septic mouse aorta by small interfering RNA
小干扰 RNA 沉默脓毒症小鼠主动脉促凋亡基因
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Matsuda N;Yamazaki M;Hattori Y
  • 通讯作者:
    Hattori Y
敗血症主臓器におけるヒスタミンH4受容体の役割(シンポジウム:H4受容体の調節機構と病態生理学的役割)
组胺H4受体在脓毒症主要器官中的作用(研讨会:H4受体的调节机制和病理生理作用)
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    松田直之;服部裕一
  • 通讯作者:
    服部裕一
Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction
  • DOI:
    10.1540/jsmr.43.117
  • 发表时间:
    2007-08-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Matsuda, Naoyuki;Hattori, Yuichi
  • 通讯作者:
    Hattori, Yuichi
敗血症性ショックにおける血管内皮細胞機能異常の意義(シンポジウム:生活習慣病から急性疾患に至るまでの血管内皮細胞障害の重要性)
血管内皮细胞功能障碍在感染性休克中的意义(研讨会:血管内皮细胞功能障碍从生活方式相关疾病到急性疾病的重要性)
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    松田直之;服部裕一
  • 通讯作者:
    服部裕一
Molecular pathophysiology of vascular endothelial dysfunction in systemic inflammatory response syndrome and sepsis
全身炎症反应综合征和脓毒症血管内皮功能障碍的分子病理生理学
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Matsuda;N;Hattori;Y
  • 通讯作者:
    Y
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HATTORI Yuichi其他文献

HATTORI Yuichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HATTORI Yuichi', 18)}}的其他基金

Prophylactic and therapeutic strategy based on the molecular pathology of septic disseminated intravascular coagulation (DIC)
基于脓毒症播散性血管内凝血(DIC)分子病理学的预防和治疗策略
  • 批准号:
    17K08586
  • 财政年份:
    2017
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Potential therapeutic application of epigenetic mechanisms involved in the septic pathology
脓毒症病理学表观遗传机制的潜在治疗应用
  • 批准号:
    23590298
  • 财政年份:
    2011
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The transcription factor AP-1 as a molecular target in sepsis therapy
转录因子 AP-1 作为脓毒症治疗的分子靶点
  • 批准号:
    20590250
  • 财政年份:
    2008
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of e-Learning contents for clinical medicine analyses supporter
为临床医学分析支持者开发电子学习内容
  • 批准号:
    19500834
  • 财政年份:
    2007
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of irradiation-induced impairment eNOS expression
辐射诱导 eNOS 表达损伤的分子机制
  • 批准号:
    12670077
  • 财政年份:
    2000
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cellular and molecular pharmacological studies on disturbance of CaィイD12+ィエD1 regulatory mechanisms in cardiomyocytes in diabetes
糖尿病心肌细胞CaD12+D1调节机制紊乱的细胞和分子药理学研究
  • 批准号:
    10670077
  • 财政年份:
    1998
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cellular and molecular pharmacological studies on a role of tyrosine kinase in the signal transduction system in cardiac cells.
酪氨酸激酶在心肌细胞信号转导系统中作用的细胞和分子药理学研究。
  • 批准号:
    07670098
  • 财政年份:
    1995
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the role of protein kinase C in cardiac contractility
蛋白激酶C在心肌收缩力中作用的研究
  • 批准号:
    03670087
  • 财政年份:
    1991
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
  • 批准号:
    23K10830
  • 财政年份:
    2023
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10539405
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
  • 批准号:
    10688080
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
  • 批准号:
    DP220101361
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10677770
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
  • 批准号:
    RGPIN-2019-04411
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
  • 批准号:
    2143019
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
  • 批准号:
    486535
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
  • 批准号:
    10330828
  • 财政年份:
    2022
  • 资助金额:
    $ 2.46万
  • 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
  • 批准号:
    2046602
  • 财政年份:
    2021
  • 资助金额:
    $ 2.46万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了